MyFinsight
Home
Blog
About
Contact
Gross proceeds
received from the sale of...
$10,480K
Gross proceeds
received from the...
$20K
Net cash provided by
financing activities
$9,559K
Canceled cashflow
$941K
Net increase in cash
$7,293K
Canceled cashflow
$2,266K
Fees related to
public offering
$939K
Fee related to the
exercise of prefunded...
$2K
Goodwill Impairment Loss
$2,000K
Accounts payable and
accrued expenses
$759K
Due from related
party
-$750K
Stock-based compensation
$309K
Issuance of common stock
to consultant for...
$96K
Other liabilities
$93K
Amortization of right-of-use
asset
$78K
Depreciation and
amortization
$8K
Net increase in cash
$7,293K
Net cash used in
operating activities
-$2,264K
Net cash used in
investing activities
-$2K
Canceled cashflow
$4,093K
Net Income Loss
-$5,500K
Purchase of property and
equipment
$2K
Due to related party
-$500K
Prepaid expenses and
other current assets
$320K
Operating lease liability
-$75K
Back
Back
Cash Flow
Ernexa Therapeutics Inc. (ERNAW)
Ernexa Therapeutics Inc. (ERNAW)
source: myfinsight.com